Nasdaq Life News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq life. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Life Today - Breaking & Trending Today

aTyr Pharma (NASDAQ:LIFE) Releases Earnings Results, Beats Estimates By $0.01 EPS

ATyr Pharma (NASDAQ:LIFE – Get Free Report) announced its earnings results on Thursday. The biotechnology company reported ($0.23) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.01, Yahoo Finance reports. The firm had revenue of $0.24 million during the quarter, compared to analyst estimates of $0.11 million. aTyr Pharma […] ....

United States , Atyr Pharma Inc , Royal Bank , Tyr Pharma , Get Free Report , Yahoo Finance , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life ,

Short Interest in aTyr Pharma, Inc. (NASDAQ:LIFE) Rises By 167.4%

ATyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 289,300 shares, an increase of 167.4% from the February 29th total of 108,200 shares. Based on an average daily volume of 521,200 shares, the short-interest ratio […] ....

United States , Tyr Pharma Company Profile , Da Davidson , Charles Schwab Investment Management Inc , Virtu Financial , Royal Bank , Atyr Pharma Inc , A Davidson , Tyr Pharma , Get Free Report , Tyr Pharma Stock , Fire Capital , Charles Schwab Investment Management , Schwab Investment Management , Tyr Pharma Company , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life ,

aTyr Pharma (NASDAQ:LIFE) Stock Rating Reaffirmed by HC Wainwright

HC Wainwright reissued their buy rating on shares of aTyr Pharma (NASDAQ:LIFE – Free Report) in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has a $35.00 price target on the biotechnology company’s stock. Separately, StockNews.com lowered aTyr Pharma from a hold rating to a sell rating in a research […] ....

United States , Blackrock Inc , Alyeska Investment Group , Tyr Pharma Company Profile , Vanguard Group Inc , Samsara Biocapital , Atyr Pharma Inc , Tyr Pharma , Free Report , Moderate Buy , Tyr Pharma Stock , Tyr Pharma Company , Get Free Report , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life , Reiterated Rating , Hc Wainwright ,

55,857 Shares in aTyr Pharma, Inc. (NASDAQ:LIFE) Purchased by Pale Fire Capital SE

Pale Fire Capital SE purchased a new position in shares of aTyr Pharma, Inc. (NASDAQ:LIFE – Free Report) during the third quarter, Holdings Channel reports. The fund purchased 55,857 shares of the biotechnology company’s stock, valued at approximately $88,000. A number of other large investors also recently added to or reduced their stakes in the […] ....

United States , Atyr Pharma Inc , Topco Ltd , Sigma Securities , Holdings Channel , Royal Bank , Pale Fire Capital , Tyr Pharma , Free Report , State Street Corp , Street Corp , Visit Holdingschannel , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

55,857 Shares in aTyr Pharma, Inc. (NASDAQ:LIFE) Bought by Pale Fire Capital SE

Pale Fire Capital SE bought a new stake in aTyr Pharma, Inc. (NASDAQ:LIFE – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 55,857 shares of the biotechnology company’s stock, valued at approximately $88,000. Pale Fire Capital […] ....

United States , Atyr Pharma Inc , Tyr Pharma Company Profile , Securities Exchange Commission , Topco Ltd , Sigma Securities , Royal Bank , Pale Fire Capital , Tyr Pharma , Free Report , Fire Capital , State Street Corp , Street Corp , Tyr Pharma Price , Tyr Pharma Company , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,